Pharmaceutical Services M&A Transactions

Clarenta Group strengthens early-stage drug development with the acquisition of Leads To Development, integrating preclinical and regulatory expertise.

AVS Bio, a portfolio company of Arlington Capital Partners, has acquired Biorbyt Ltd., enhancing its biomaterials offerings and global reach in life sciences research.

Novotech strengthens its bioanalytical capabilities in Australia by acquiring Agilex Biolabs from Healius, enhancing services for the life sciences sector.

Kobayashi Pharmaceutical

Private equity firms CVC Capital Partners and NSSK are in talks for a potential $3.2 billion acquisition of Japanese healthcare firm Kobayashi Pharmaceutical.

Copeland strengthens its healthcare and life sciences cold chain capabilities by acquiring environmental monitoring specialist Dickson.